Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti EGFR MAb ICR62: A two-pronged attack for tumour therapy.

Helmout Modjtahedi; David K. Moscatello; Gary Box; Margaret Green; Christine Shotton; David J. Lamb; Lesley J. Reynolds; Albert J. Wong; Christopher Dean; Hilary Thomas; Suzanne Eccles

doi:10.1002/ijc.11055

Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti EGFR MAb ICR62: A two-pronged attack for tumour therapy.

Helmout Modjtahedi
, David K. Moscatello
, Gary Box
, Margaret Green
, Christine Shotton
, David J. Lamb
, Lesley J. Reynolds
, Albert J. Wong
, Christopher Dean
, Hilary Thomas
, Suzanne Eccles

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	273-280
Journal	International Journal of Cancer
Volume	105
Issue number	2
DOIs	https://doi.org/10.1002/ijc.11055
Publication status	Published - Jun 2003

Keywords

EGFR
EGFRvIII
monoclonal antibody therapy
ADCC
metastasis
Allied health professions and studies

Access to Document

10.1002/ijc.11055

http://dx.doi.org/10.1002/ijc.11055

Cite this

Modjtahedi, H., Moscatello, D. K., Box, G., Green, M., Shotton, C., Lamb, D. J., Reynolds, L. J., Wong, A. J., Dean, C., Thomas, H., & Eccles, S. (2003). Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti EGFR MAb ICR62: A two-pronged attack for tumour therapy. International Journal of Cancer, 105(2), 273-280. https://doi.org/10.1002/ijc.11055

@article{e9d584bf46f74413ad5a19d2258d41db,

title = "Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti EGFR MAb ICR62: A two-pronged attack for tumour therapy.",

keywords = "EGFR, EGFRvIII, monoclonal antibody therapy, ADCC, metastasis, Allied health professions and studies",

author = "Helmout Modjtahedi and Moscatello, \{David K.\} and Gary Box and Margaret Green and Christine Shotton and Lamb, \{David J.\} and Reynolds, \{Lesley J.\} and Wong, \{Albert J.\} and Christopher Dean and Hilary Thomas and Suzanne Eccles",

year = "2003",

month = jun,

doi = "10.1002/ijc.11055",

language = "English",

volume = "105",

pages = "273--280",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley and Sons Inc",

number = "2",

}

Modjtahedi, H, Moscatello, DK, Box, G, Green, M, Shotton, C, Lamb, DJ, Reynolds, LJ, Wong, AJ, Dean, C, Thomas, H & Eccles, S 2003, 'Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti EGFR MAb ICR62: A two-pronged attack for tumour therapy.', International Journal of Cancer, vol. 105, no. 2, pp. 273-280. https://doi.org/10.1002/ijc.11055

TY - JOUR

T1 - Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti EGFR MAb ICR62

T2 - A two-pronged attack for tumour therapy.

AU - Modjtahedi, Helmout

AU - Moscatello, David K.

AU - Box, Gary

AU - Green, Margaret

AU - Shotton, Christine

AU - Lamb, David J.

AU - Reynolds, Lesley J.

AU - Wong, Albert J.

AU - Dean, Christopher

AU - Thomas, Hilary

AU - Eccles, Suzanne

PY - 2003/6

Y1 - 2003/6

KW - EGFR

KW - EGFRvIII

KW - monoclonal antibody therapy

KW - ADCC

KW - metastasis

KW - Allied health professions and studies

U2 - 10.1002/ijc.11055

DO - 10.1002/ijc.11055

M3 - Article

SN - 0020-7136

VL - 105

SP - 273

EP - 280

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 2

ER -